AXSM Stock Analysis: Buy, Sell, or Hold?
AXSM - Axsome Therapeutics, Inc
$232.27
-3.05 (-1.30%)
▼
5d:
+5.47%
30d:
+26.11%
90d:
+26.97%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
AXSM is down 3.2% this week, but smart money is accumulating calls. Top strike: $210 2026-06-18 with 701 OI. Call ratio: 68% View Scanner →
Strength: 3.4/10
Get Alerted When AXSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called AXSM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AXSM is 7.1% above its trading range ($216.79). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AXSM is 7.1% above its trading range ($216.79). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$206.22
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$128.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXSM is currently trading at $232.27, which is considered extended relative to its 30-day fair value range of $176.38 to $216.79. From a valuation perspective, the stock is trading at a discount (Forward PE: 39.5) compared to its historical average (119.8). Remarkably, the market is currently pricing in an annual earnings decline of 30.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AXSM is in a uptrend. The price is approaching resistance at $235.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $270.28 (+16.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AXSM is in a uptrend. The price is approaching resistance at $235.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $270.28 (+16.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$176.38 -
$216.79
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.5%
Protect Your Profits
AXSM is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.1% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($270.28)
- CAUTION: Extended 7.1% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$176.38 -
$216.79
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$11.19
(4.8%)
Support & Resistance Levels
Support Level
$198.02
Resistance Level
$235.92
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
39.45
Wall Street Target
$270.28
(+16.4%)
Revenue Growth (YoY)
57.4%
Profit Margin
-26.6%
Valuation Discount vs History
-30.9% cheaper
PE vs Historical
39.5 vs 119.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-30.9%
(market-implied from PE analysis)
1-Year Target
$209.04
(-10%)
2-Year Target
$188.14
(-19%)
3-Year Target
$169.32
(-27%)
3-Yr Target (if PE normalizes)
(PE: 39→120)
$514.15
(+121%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 39.5 to 119.8
Stabilization Target:
$705.29
(+203.6%)
PE Expansion Potential:
+203.6%
Share & Embed Analysis
Last updated: May 14, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Ari Maizel
SELL
7500 shares
2026-04-22
Mark Coleman
SELL
25000 shares
2026-02-26
Mark L Jacobson
SELL
35378 shares
2026-02-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 62 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$550 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 60 BUY |
Advanced AXSM Option Strategies
Professional options setups generated by AI based on today's AXSM price and gamma walls.
